Business description: ALS Limited

ALS Limited is an Australia-based company engaged in the provision of professional technical services, primarily in the areas of testing, measurement and inspection. The Company provides comprehensive testing solutions to clients in a range of industries around the world. The Company operates through two segments: Commodities and Life Sciences. Its Commodities segment provides assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry, such as coal sampling, analysis and certification, formation evaluation services, tribology testing services and related analytical testing. The Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments around the world in making informed decisions about environmental, food and pharmaceutical, electronics, consumer products, and animal health.

Number of employees: 20,515

Sales by Activity: ALS Limited

Fiscal Period: March 2021 (AUD) 2022 (AUD) 2023 (AUD) 2024 (AUD) 2025 (AUD)

Life Sciences

930M - - - 1.91B

Commodities

625M 819M 1.09B 1.09B 1.09B

Life Sciences - Nuvisan

- 73.8M 142M 124M -

Life Sciences Excl Nuvisan

- 1.08B 1.19B 1.38B -

Industrial

207M 209M - - -

Elimination Nuvisan

- -73.8M -142M -124M -

Geographical breakdown of sales: ALS Limited

Fiscal Period: March 2021 (AUD) 2022 (AUD) 2023 (AUD) 2024 (AUD) 2025 (AUD)

EMENA (Europe, Middle East, North Africa)

466M 533M 514M 594M 1.05B

Americas

588M 793M 946M 1B 1.03B

Asia/Pacific

672M 740M 765M 810M 854M

Africa

34.7M 42.9M 54.5M 57.6M 65.5M

Executive Committee: ALS Limited

Manager TitleAgeSince
Chief Executive Officer - 06/03/2023
Director of Finance/CFO 59 31/01/2024
Investor Relations Contact - -
General Counsel - 30/09/2024
Director of Finance/CFO - -

Composition of the Board of Directors: ALS Limited

Director TitleAgeSince
Director/Board Member 76 31/01/2012
Director/Board Member 56 14/01/2019
Director/Board Member 65 20/11/2019
Director/Board Member 65 31/10/2022
Director/Board Member - 06/03/2023
Chairman 65 30/07/2024
Director/Board Member 67 29/02/2024
Director/Board Member 61 23/03/2025
Director/Board Member - 31/08/2025

Shareholders: ALS Limited

NameEquities%Valuation
Faircase Pty Ltd.
1.65 %
8,376,286 1.65 % 119 M $
Australian Foundation Investment Co. Ltd. (Invt Mgmt)
1.382 %
7,012,161 1.382 % 100 M $
1.19 %
6,038,017 1.19 % 86 M $
State Street Global Advisors Trust Co.
0.7152 %
3,630,184 0.7152 % 52 M $
Pengana Capital Ltd.
0.5371 %
2,725,801 0.5371 % 39 M $

Company details: ALS Limited

ALS Ltd.

Bowen Hills

4006, Brisbane

+61 7 3367 7900

http://www.alsglobal.com
address ALS Limited(ALQ)

Group companies: ALS Limited

NameCategory and Sector
Miscellaneous Commercial Services
Miscellaneous Commercial Services

Other Business Support Services

Change 5d. change 1-year change 3-years change Capi.($)
+1.24%+1.93%+49.70%+71.71% 8.08B
+0.93%+2.42%-12.92%+57.74% 71.68B
+0.85%+0.84%+6.97%+78.16% 19.37B
+1.53%+7.64%+9.86%+13.22% 15.34B
+2.12%+4.93%+9.99%+12.11% 15.14B
+4.50%+30.42%+9.16%+20.84% 10.34B
+0.82%+8.05%-22.42%-17.82% 6.27B
-0.41%-0.41%+55.24%+71.71% 6.09B
+1.17%+2.72%+5.22%-16.32% 5.04B
+1.21%+8.85%-29.03%-4.59% 4.98B
Average +1.40%+6.33%+8.18%+28.68% 16.23B
Weighted average by Cap. +1.30%+4.83%+0.52%+43.45%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
22.14AUD
Average target price
23.80AUD
Spread / Average Target
+7.48%

Quarterly revenue - Rate of surprise